1
                                                                    Exhibit 99.2


                               GENE LOGIC INC.

                    PROXY SOLICITED BY THE BOARD OF DIRECTORS
                      FOR A SPECIAL MEETING OF STOCKHOLDERS
                       TO BE HELD ON _______________, 1998

           The undersigned hereby appoints Michael J. Brennan, M.D., Ph.D. and
Mark D. Gessler, and each of them, as attorneys and proxies of the undersigned,
with full power of substitution, to vote all of the shares of stock of Gene
Logic Inc. ("Gene Logic") which the undersigned may be entitled to vote at a
Special Meeting of Stockholders of Gene Logic. to be held at the offices of Gene
Logic at 708 Quince Orchard Road, Gaithersburg, MD 20878, on __________,
__________________, 1998 at 10:00 a.m., local time, and at any and all
postponements, continuations and adjournments thereof (the "Gene Logic Special
Meeting"), with all powers that the undersigned would possess if personally
present, upon and in respect of the following matters and in accordance with the
following instructions, with discretionary authority as to any and all other
matters that may properly come before the Special Meeting.

           THIS PROXY, WHEN PROPERLY EXECUTED, WILL BE VOTED IN THE MANNER
DIRECTED HEREIN BY THE UNDERSIGNED STOCKHOLDER. UNLESS A CONTRARY DIRECTION IS
INDICATED, THIS PROXY WILL BE VOTED FOR PROPOSAL 1, AS MORE SPECIFICALLY
DESCRIBED IN THE NOTICE AND IN THE PROSPECTUS/JOINT PROXY STATEMENT TRANSMITTED
IN CONNECTION WITH THE GENE LOGIC SPECIAL MEETING. ANY HOLDER WHO WISHES TO
WITHHOLD THE DISCRETIONARY AUTHORITY REFERRED TO IN PROPOSAL 2 BELOW SHOULD MARK
A LINE THROUGH THE ENTIRE PROPOSAL.

MANAGEMENT RECOMMENDS A VOTE FOR PROPOSALS 1 AND 2.


                  
PROPOSAL 1           To (i) approve and adopt the Agreement and Plan of Merger and Reorganization dated as of July 6, 1998 (the
                     "Merger Agreement") among Gene Logic, Gene Logic Acquisition Corp., a Delaware corporation and wholly owned
                     subsidiary of Gene Logic ("Merger Sub") and Oncormed, Inc., a Delaware corporation ("Oncormed"), and (ii)
                     approve the merger of Oncormed with and into Merger Sub (the "Merger"), pursuant to which Oncormed will cease 
                     to exist and Merger Sub will be the surviving corporation (the "Merger Proposal").

           [  ]      FOR                    [  ]         AGAINST                      [  ]         ABSTAIN

PROPOSAL 2           In the Board's discretion, to act upon any matters incidental to the foregoing and such other business as may
                     properly come before the Gene Logic Special Meeting.


Receipt of the Prospectus/Joint Proxy Statement dated _____________, 1998 is
hereby acknowledged.

Dated ______________, 1998
                                   --------------------------------------

                                   --------------------------------------
                                               SIGNATURE(S)

                Please sign exactly as your name appears hereon. If the
                stock is registered in the names of two or more persons, each
                should sign. Executors, administrators, trustees, guardians and
                attorneys-in-fact should add their titles. If signer is a
                corporation, please give full corporate name and have a duly
                authorized officer sign, stating title. If signer is a
                partnership, please sign in partnership name by an authorized
                person.


PLEASE VOTE, DATE AND PROMPTLY RETURN THIS PROXY IN THE ENCLOSED RETURN ENVELOPE
WHICH IS POSTAGE PREPAID IF MAILED IN THE UNITED STATES.